日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Repurposing AZD5438 and Dabrafenib for Cisplatin-Induced AKI

重新利用 AZD5438 和达拉非尼治疗顺铂诱发的 AKI

Chithra K Pushpan, Daniel F Kresock, Matthew A Ingersoll, Richard D Lutze, Darby L Keirns, William J Hunter, Khalid Bashir, Tal Teitz

Dabrafenib protects from cisplatin-induced hearing loss in a clinically relevant mouse model

达拉非尼在临床相关小鼠模型中预防顺铂引起的听力损失

Matthew A Ingersoll, Richard D Lutze, Chithra K Pushpan, Regina G Kelmann, Huizhan Liu, Mark T May, William J Hunter, David Zz He, Tal Teitz